Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization

Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients

(2009) Marta Pestrin et al.   BREAST CANCER RESEARCH AND TREATMENT

Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer

(2009) Panayiotis A. Theodoropoulos et al.   CANCER LETTERS

Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression

(2009) Koji Morimoto et al.   CANCER SCIENCE

Circulating Tumor Cells: A Useful Predictor of Treatment Efficacy in Metastatic Breast Cancer

(2009) Minetta C. Liu et al.   JOURNAL OF CLINICAL ONCOLOGY

Circulating Tumor Cells and [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Outcome Prediction in Metastatic Breast Cancer

(2009) Ugo De Giorgi et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies

(2008) Mitra Tewes et al.   BREAST CANCER RESEARCH AND TREATMENT

Circulating tumor cells in metastatic breast cancer

(2008) Shaheenah Dawood et al.   CANCER

Circulating Tumor Cells and Bone Marrow Micrometastasis

(2008) C. Alix-Panabieres et al.   CLINICAL CANCER RESEARCH

Chemoresistance profile of circulating tumor cells: Toward a clinical benefit?

(2008) Paola Gazzaniga et al.   INTERNATIONAL JOURNAL OF CANCER